Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

ABL Kinase Domain Mutation in Chronic Myeloid Leukemia - Compliance to Imatinib Matters

Jayachandran PK, MD MRCP, DM, Trivadi S Ganesan, MD FRCP, PhD, Nikita Mehra, MD DM, Krishnarathinam Kannan, MD DM, Manikandan Dhanushkodi, MD DM, Venkatraman Radhakrishnan, MD DM, Arun Kumar Rajan, MD DM, Joshi Archit Girishchandra, MD DM, Gangothri Selvarajan, MD DM, Parathan Karunakaran, MD DM, Tenali Gnana Sagar, MD DM

Blood (2019) 134 (Supplement_1): 1654.

https://doi.org/10.1182/blood-2019-125998

Published: 2019

Journal Articles

Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure - Data from a Large Tertiary Center in India

Chaitanya Krishna Puligundla, MD, Sadashivudu Gundeti, MD, Stalin Bala, MD, Ashok Pillai, MD, Praveen Adusumilli, MD, Madhav Danthala, MD, Meher Lakshmi Konatam, DM, Lakshmi Srinivas Maddali, DM

Blood (2016) 128 (22): 1910.

https://doi.org/10.1182/blood.V128.22.1910.1910

Published: 2016

Journal Articles

Imatinib Resistance Mutation Analysis Pattern In Chronic Myeloid Leukemia (CML) Patients on Imatinib In Indian Population.

Mukul Goyal, MD, K.C. Lakshmaiah, MD, DM, K.Govind Babu, MD, DM, Amit Rauthan, MD, DM, Linu Abraham Jacob, MD, DM, Singh Tejinder, MD, DM, L.K. Rajeev, MD, G.Mehar Kumar, MD, Vineetha Unnikrishnan, MD

Blood (2010) 116 (21): 4491.

https://doi.org/10.1182/blood.V116.21.4491.4491

Published: 2010

Journal Articles

Tumor Marker CA 15-3 in Hematological Malignancies.

Zoi Saouli, MD, Athanasios Papadopoulos, Georgia Kaiafa, Fotios Girtovitis, Georg Charisopoulos, MD, Zisis Kontoninas, MD, Anestis Zantidis, MD, Charalambos Andreadis

Blood (2006) 108 (11): 4329.

https://doi.org/10.1182/blood.V108.11.4329.4329

Published: 2006

Journal Articles

Cross Reaction of Antibody Against Helicobacter Pylori Urease B with Platelet Glycoprotein IIIa and Its Significance in the Pathogenesis of ITP.

Zhaoyue Wang, Yanyan Bai, Xia Bai, Wei Zhang, Changgeng Ruan

Blood (2006) 108 (11): 1084.

https://doi.org/10.1182/blood.V108.11.1084.1084

Published: 2006

Journal Articles

Factor VIII coagulant antigen in hemophilic plasma: a comparison of five alloantibodies

HM Reisner, WA Price, PM Blatt, ES Barrow, JB Graham

Blood (1980) 56 (4): 615–619.

https://doi.org/10.1182/blood.V56.4.615.615

Published: 1980

NARROW

ABL Kinase Domain Mutation in Chronic Myeloid Leukemia - Compliance to Imatinib Matters

Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure - Data from a Large Tertiary Center in India

Imatinib Resistance Mutation Analysis Pattern In Chronic Myeloid Leukemia (CML) Patients on Imatinib In Indian Population.

Tumor Marker CA 15-3 in Hematological Malignancies.

Cross Reaction of Antibody Against Helicobacter Pylori Urease B with Platelet Glycoprotein IIIa and Its Significance in the Pathogenesis of ITP.

Factor VIII coagulant antigen in hemophilic plasma: a comparison of five alloantibodies

Email alerts

ASH Publications

American Society of Hematology

ABL Kinase Domain Mutation in Chronic Myeloid Leukemia - Compliance to Imatinib Matters

Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure - Data from a Large Tertiary Center in India

Imatinib Resistance Mutation Analysis Pattern In Chronic Myeloid Leukemia (CML) Patients on Imatinib In Indian Population.

Tumor Marker CA 15-3 in Hematological Malignancies.

Cross Reaction of Antibody Against Helicobacter Pylori Urease B with Platelet Glycoprotein IIIa and Its Significance in the Pathogenesis of ITP.

Factor VIII coagulant antigen in hemophilic plasma: a comparison of five alloantibodies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only